Urogen Pharma(GB:0XOD)
$31.92+2.27 (+7.66%)
GB:0XOD
Urogen Pharma financials statements
$31.92
At close:+2.27 (+7.66%)
Urogen Pharma (0XOD) Income Statement
1 Followers
Urogen Pharma Income Statement
Last quarter (Q3 2026), Urogen Pharma's total revenue was $89.00M, an increase of 223.85% from the same quarter last year. In Q3, Urogen Pharma's net income was $-1.46M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 109.79M | $ 90.40M | $ 82.71M | $ 64.36M | $ 48.04M | |
| $ 97.34M | $ 81.52M | $ 73.35M | $ 56.70M | $ 42.88M | |
| $ 222.20M | $ 178.30M | $ 138.89M | $ 135.74M | $ 135.18M | |
| Depreciation and Amortization | $ 2.41M | $ 1.19M | $ 1.71M | $ 1.82M | $ 1.77M |
| $ -135.66M | $ -94.50M | $ -60.35M | $ -76.21M | $ -107.60M | |
| $ -124.86M | $ -96.78M | $ -65.54M | $ -79.04M | $ -92.29M | |
| $ -28.55M | $ -27.26M | $ -32.79M | $ -28.99M | $ -17.08M | |
| $ -153.42M | $ -124.04M | $ -98.32M | $ -108.03M | $ -109.37M | |
| $ -153.49M | $ -126.87M | $ -102.24M | $ -109.78M | $ -110.82M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.19 | $ -2.96 | $ -3.55 | $ -4.79 | $ -4.96 |
| Diluted EPS | $ -3.19 | $ -2.96 | $ -3.55 | $ -4.79 | $ -4.96 |
| Weighted Average Shares Outstanding | 48.12M | 42.88M | 28.83M | 22.81M | 22.35M |
| Weighted Average Shares Outstanding (Diluted) | 48.12M | 42.88M | 28.83M | 22.81M | 22.35M |
Currency in USD

